National Guideline Clearinghouse | Apremilast for treating moderate to severe plaque psoriasis.

National Guideline Clearinghouse | Apremilast for treating moderate to severe plaque psoriasis.

National Institute for Health and Care Excellence (NICE)

• Apremilast for treating moderate to severe plaque psoriasis.

Guideline Title Apremilast for treating moderate to severe plaque psoriasis. Bibliographic Source(s) National Institute for Health and Care Excellence (NICE). Apremilast for treating moderate to severe plaque psoriasis. London (UK): National Institute for Health and Care Excellence (NICE); 2015 Nov 25. 48 p. (Technology appraisal guidance; no. 368).  Guideline Status This is the current release of the guideline. This guideline meets NGC's 2013 (revised) inclusion criteria.